BDBM418793 N-methyl-N-{3-[({2-[(5-morpholin-4- ylpyridin-2-yl)amino]-5- (trifluoromethyl)pyrimidin-4- yl}amino)methyl]pyridin-2- yl]methanesulfonamide (293), trifiuoroacetic acid salt::US10450297, Example 293

SMILES CN(c1ncccc1CNc1nc(Nc2ccc(cn2)N2CCOCC2)ncc1C(F)(F)F)S(C)(=O)=O

InChI Key InChIKey=POOPCDXGFLTQAG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 418793   

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandPNGBDBM418793(N-methyl-N-{3-[({2-[(5-morpholin-4- ylpyridin-2-yl...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent